ICUI

SEC source: 0001698998-25-000001 · edgardoc.xml · derivative · entry 7

Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,061

Underlying: Common Stock · 2,153 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: These securities are Restricted Stock Units.

F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

F3 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date.

F4 · derivative.expiration_date: These are restricted stock units that fully vest 3 years from the grant date.

SEC source: 0001698998-25-000001 · edgardoc.xml · nonDerivative · entry 4

Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,565

SEC source: 0001698998-25-000001 · edgardoc.xml · nonDerivative · entry 3

Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,518

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: These securities are Restricted Stock Units.

SEC source: 0002013412-25-000001 · edgardoc.xml · derivative · entry 6

Sousa Ben · CIK 0002013412 · Chief Information Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,098

Underlying: Common Stock · 4,227 shares

Expires not disclosed

F1 · security: These securities are Restricted Stock Units.

F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

F3 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date.

F4 · derivative.expiration_date: These are restricted stock units that fully vest 3 years from the grant date.

SEC source: 0002013412-25-000001 · edgardoc.xml · derivative · entry 5

Sousa Ben · CIK 0002013412 · Chief Information Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 430 shares

Expires 2025-03-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: These securities are Restricted Stock Units.

F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

F3 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date.

F4 · derivative.expiration_date: These are restricted stock units that fully vest 3 years from the grant date.

SEC source: 0002013412-25-000001 · edgardoc.xml · nonDerivative · entry 2

Sousa Ben · CIK 0002013412 · Chief Information Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,489

SEC source: 0002013412-25-000001 · edgardoc.xml · nonDerivative · entry 1

Sousa Ben · CIK 0002013412 · Chief Information Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,749

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: These securities are Restricted Stock Units.

SEC source: 0001669639-25-000002 · edgardoc.xml · derivative · entry 6

Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,612

Underlying: Common Stock · 7,044 shares

Expires not disclosed

F1 · security: These securities are Restricted Stock Units.

F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

F3 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date.

F4 · derivative.expiration_date: These are restricted stock units that fully vest 3 years from the grant date.

SEC source: 0001669639-25-000002 · edgardoc.xml · derivative · entry 5

Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,073 shares

Expires 2025-03-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: These securities are Restricted Stock Units.

F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

F3 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date.

F4 · derivative.expiration_date: These are restricted stock units that fully vest 3 years from the grant date.

SEC source: 0001669639-25-000002 · edgardoc.xml · nonDerivative · entry 2

Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,930

SEC source: 0001669639-25-000002 · edgardoc.xml · nonDerivative · entry 1

Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,555

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: These securities are Restricted Stock Units.

SEC source: 0001410442-25-000002 · edgardoc.xml · derivative · entry 4

Jain Vivek · CIK 0001410442 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,218 shares

Expires 2025-03-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: These securities are Restricted Stock Units.

F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

F3 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date.

F4 · derivative.expiration_date: These are restricted stock units that fully vest 3 years from the grant date.

SEC source: 0001410442-25-000002 · edgardoc.xml · nonDerivative · entry 2

Jain Vivek · CIK 0001410442 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 106,036

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: These securities are Restricted Stock Units.

SEC source: 0001410442-25-000002 · edgardoc.xml · nonDerivative · entry 1

Jain Vivek · CIK 0001410442 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 102,818

SEC source: 0001698998-25-000001 · edgardoc.xml · derivative · entry 6

Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,214

Underlying: Common Stock · 4,755 shares

Expires not disclosed

F1 · security: These securities are Restricted Stock Units.

F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

F3 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date.

F4 · derivative.expiration_date: These are restricted stock units that fully vest 3 years from the grant date.

SEC source: 0001698998-25-000001 · edgardoc.xml · derivative · entry 5

Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 966 shares

Expires 2025-03-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: These securities are Restricted Stock Units.

F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

F3 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date.

F4 · derivative.expiration_date: These are restricted stock units that fully vest 3 years from the grant date.

SEC source: 0001698998-25-000001 · edgardoc.xml · nonDerivative · entry 2

Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,365

SEC source: 0001698998-25-000001 · edgardoc.xml · nonDerivative · entry 1

Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,832

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: These securities are Restricted Stock Units.

SEC source: 0001727477-25-000001 · edgardoc.xml · derivative · entry 4

Voigtlander Christian B. · CIK 0001727477 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,566

Underlying: Common Stock · 10,566 shares

Expires not disclosed

F1 · security: These securities are Restricted Stock Units.

F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

F3 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date.

F4 · derivative.expiration_date: These are restricted stock units that fully vest 3 years from the grant date.

SEC source: 0001727477-25-000001 · edgardoc.xml · derivative · entry 3

Voigtlander Christian B. · CIK 0001727477 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,146 shares

Expires 2025-03-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: These securities are Restricted Stock Units.

F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

F3 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date.

F4 · derivative.expiration_date: These are restricted stock units that fully vest 3 years from the grant date.

SEC source: 0001727477-25-000001 · edgardoc.xml · nonDerivative · entry 2

Voigtlander Christian B. · CIK 0001727477 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 933

SEC source: 0001727477-25-000001 · edgardoc.xml · nonDerivative · entry 1

Voigtlander Christian B. · CIK 0001727477 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,146

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: These securities are Restricted Stock Units.

SEC source: 0001804831-25-000001 · edgardoc.xml · derivative · entry 3

Bonnell Brian Michael · CIK 0001804831 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,566

Underlying: Common Stock · 10,566 shares

Expires not disclosed

F1 · security: These securities are Restricted Stock Units.

F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

F3 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date.

F4 · derivative.expiration_date: These are restricted stock units that fully vest 3 years from the grant date.

SEC source: 0001804831-25-000001 · edgardoc.xml · derivative · entry 2

Bonnell Brian Michael · CIK 0001804831 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,146 shares

Expires 2025-03-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: These securities are Restricted Stock Units.

F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

F3 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date.

F4 · derivative.expiration_date: These are restricted stock units that fully vest 3 years from the grant date.

SEC source: 0001804831-25-000001 · edgardoc.xml · nonDerivative · entry 1

Bonnell Brian Michael · CIK 0001804831 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,100

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: These securities are Restricted Stock Units.

SEC source: 0001410442-25-000003 · edgardoc.xml · derivative · entry 1

Jain Vivek · CIK 0001410442 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,848

Underlying: Common Stock · 15,848 shares

Expires not disclosed

F1 · security: These securities are Restricted Stock Units.

F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

F3 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date.

F4 · derivative.expiration_date: These are restricted stock units that fully vest 3 years from the grant date.

SEC source: 0001410442-25-000001 · edgardoc.xml · derivative · entry 4

Jain Vivek · CIK 0001410442 · Director · Chairman and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,373 shares

Expires 2025-02-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2024.

SEC source: 0001410442-25-000001 · edgardoc.xml · nonDerivative · entry 2

Jain Vivek · CIK 0001410442 · Director · Chairman and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 104,593

F2 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2024.

F3 · price: All shares sold were sold at the exact price disclosed.

SEC source: 0001410442-25-000001 · edgardoc.xml · nonDerivative · entry 1

Jain Vivek · CIK 0001410442 · Director · Chairman and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 105,966

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2024.

SEC source: 0001698998-24-000005 · edgardoc.xml · nonDerivative · entry 1

Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,866

F1 · price: All shares sold were sold at the exact price disclosed.

SEC source: 0001410442-24-000008 · edgardoc.xml · derivative · entry 6

Jain Vivek · CIK 0001410442 · Director · Chairman and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,373

Underlying: Common Stock · 12,000 shares

Expires 2025-02-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · shares: The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2024.

SEC source: 0001410442-24-000008 · edgardoc.xml · nonDerivative · entry 4

Jain Vivek · CIK 0001410442 · Director · Chairman and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 104,593

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2024.

F4 · price: All shares sold were sold at the exact price disclosed.

SEC source: 0001410442-24-000008 · edgardoc.xml · nonDerivative · entry 3

Jain Vivek · CIK 0001410442 · Director · Chairman and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 104,671

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2024.

F3 · price: The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $162.79 to $163.68, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.

SEC source: 0001410442-24-000008 · edgardoc.xml · nonDerivative · entry 2

Jain Vivek · CIK 0001410442 · Director · Chairman and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 112,921

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2024.

F2 · price: The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $161.714 to $162.710, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.

SEC source: 0001410442-24-000008 · edgardoc.xml · nonDerivative · entry 1

Jain Vivek · CIK 0001410442 · Director · Chairman and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 116,593

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001645866-24-000002 · edgardoc.xml · derivative · entry 4

Greenberg David C. · CIK 0001645866 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,942

Underlying: Common Stock · 972 shares

Expires 2025-06-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001645866-24-000002 · edgardoc.xml · nonDerivative · entry 2

Greenberg David C. · CIK 0001645866 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,037

F1 · price: All shares sold were sold at the exact price disclosed.

SEC source: 0001645866-24-000002 · edgardoc.xml · nonDerivative · entry 1

Greenberg David C. · CIK 0001645866 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,009

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001727477-24-000006 · edgardoc.xml · derivative · entry 3

Voigtlander Christian B. · CIK 0001727477 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 55,556

Underlying: Common Stock · 1,430 shares

Expires 2025-06-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001727477-24-000006 · edgardoc.xml · nonDerivative · entry 2

Voigtlander Christian B. · CIK 0001727477 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

F1 · price: All shares sold were sold at the exact price disclosed.

SEC source: 0001727477-24-000006 · edgardoc.xml · nonDerivative · entry 1

Voigtlander Christian B. · CIK 0001727477 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,430

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001727477-24-000005 · edgardoc.xml · derivative · entry 7

Voigtlander Christian B. · CIK 0001727477 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 56,986

Underlying: Common Stock · 7,719 shares

Expires 2025-06-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001727477-24-000005 · edgardoc.xml · nonDerivative · entry 5

Voigtlander Christian B. · CIK 0001727477 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

F3 · price: The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $160.09 to $160.24, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.

SEC source: 0001727477-24-000005 · edgardoc.xml · nonDerivative · entry 4

Voigtlander Christian B. · CIK 0001727477 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 206

F2 · price: The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $159.00 to $159.86, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.

SEC source: 0001727477-24-000005 · edgardoc.xml · nonDerivative · entry 3

Voigtlander Christian B. · CIK 0001727477 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,719

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001727477-24-000005 · edgardoc.xml · derivative · entry 6

Voigtlander Christian B. · CIK 0001727477 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 64,705

Underlying: Common Stock · 1,962 shares

Expires 2025-06-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001727477-24-000005 · edgardoc.xml · nonDerivative · entry 2

Voigtlander Christian B. · CIK 0001727477 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

F1 · price: The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $169.00 to $169.45, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.

SEC source: 0001727477-24-000005 · edgardoc.xml · nonDerivative · entry 1

Voigtlander Christian B. · CIK 0001727477 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,962

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001410442-24-000007 · edgardoc.xml · derivative · entry 7

Jain Vivek · CIK 0001410442 · Director · Chairman and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 13,373

Underlying: Common Stock · 12,000 shares

Expires 2025-02-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2024.

SEC source: 0001410442-24-000007 · edgardoc.xml · nonDerivative · entry 5

Jain Vivek · CIK 0001410442 · Director · Chairman and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 104,593

F2 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2024.

F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $173.44 to $173.91, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.